Back to search

Netherlands· NL-24fb851673ed

GalenVita 3,33 GBq radionuclidegenerator

A other diagnostic radiopharmaceuticals product containing germanium [68ge]tetrachloride, gallium [68ga]trichloride, registered in Netherlands by Curium Romania SRL. The same ATC class is registered in 10 of our 19 countries.

ATC V09X

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedGalenVita 3,33 GBq radionuclidegenera…ATCV09XREGISTER NO.NL-24fb851673edPACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Germanium [68ge]tetrachloride, gallium [68ga]trichloride is registered in 10 of 19 countries.

Countries holding a registration under ATC V09X (other diagnostic radiopharmaceuticals), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose

Germanium [68ge]tetrachloride, gallium [68ga]trichloride · ATC V09X

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
GERMANIUM [68Ge]TETRACHLORIDE, GALLIUM [68Ga]TRICHLORIDE
Manufacturer
Curium Romania SRL
Country
Netherlands (NL)
ATC code
V09X
ATC class
OTHER DIAGNOSTIC RADIOPHARMACEUTICALS
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/25/2004

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5707899-a04e-4eb6-be74-52c1a30b7dac
GET /v1/drugs/f5707899-a04e-4eb6-be74-52c1a30b7dac?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Radionuclide generator",
  "route": "Toedieningsweg niet van toepassing",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/galenvita-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Other Diagnostic Radiopharmaceuticals",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp136490",
  "excipients": [
    "VOORVERPAKTE KOLOM GEVULD MET TITANIUMDIOXIDE EN AFGEDICHT MET POLYMEER AFSLUITERS",
    "WATER VOOR INJECTIE",
    "ZOUTZUUR (E 507)"
  ],
  "substances": [
    "GERMANIUM [68Ge]TETRACHLORIDE, GALLIUM [68Ga]TRICHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2026/01/08",
  "procedure_number": "EMEA/H/C/006639",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/25/2004",
  "additional_monitoring": "N"
}

See everything about germanium [68ge]tetrachloride, gallium [68ga]trichloride.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.